In situ cytokine production by breast cancer tumor-infiltrating lymphocytes

Annals of Surgical Oncology

Volumn 3, Issue 2, 1996, Pages 176-184

  Camp, Benjamin J ^a   Dyhrman, Sonya T ^a   Memoli, Vincent A ^a   Mott, Leila A ^a   Barth Jr , Richard J ^a,b  

^a NORRIS COTTON CANCER CENTER   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

Breast cancer; Immunohistochemistry; Interleukin 2; Interleukin 4; Tumor growth factor beta 1; Tumor infiltrating lymphocyte

Indexed keywords

CYTOKINE; PARAFFIN;

ARTICLE; BIOSYNTHESIS; BREAST TUMOR; ENZYME IMMUNOASSAY; FEMALE; HUMAN; LYMPH NODE METASTASIS; METABOLISM; MORTALITY; PAGET NIPPLE DISEASE; PATHOLOGY; PROGNOSIS; SURVIVAL RATE; TUMOR ASSOCIATED LEUKOCYTE;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CYTOKINES; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; LYMPHOCYTES, TUMOR-INFILTRATING; PARAFFIN EMBEDDING; PROGNOSIS; SURVIVAL RATE;

EID: 0030096574     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02305798     Document Type: Article

References (25)

1. Eremin O, Coombs RA, Prospere TA, Plumb D. T-lymphocyte subpopulations infiltrating human mammary carcinomas. J Natl Cancer Inst 1982;69:1-8.
2. Shimokawara I, Imamura M, Yamanaka N, Ishii Y, Kikuchi K. Identification of lymphocyte subpopulations in human breast cancer tissue and its significance: an immunoperoxidase study with anti-human T- and B-cell sera. Cancer 1982; 49:1456-64.
3. Wintzer H, Bohle W, von Kleist S. Study of the relationship between immunohistologically demonstrated lymphocytes infiltrating human breast carcinomas and patients' survival. Can Res Clin Oncol 1991;117:163-7.
4. Whitford P, Mallon EA, George WD, Campbell AM. Flow cytometric analysis of tumor infiltrating lymphocytes in breast cancer. Br J Can 1990;62:971-5.
5. Schwartzentruber DJ, Solomon D, Rosenberg SA, Topalian SL. Characterization of lymphocytes infiltrating human breast cancer: specific immune reactivity detected by measuring cytokine secretion. J Immunother 1992;12:1-12.
6. Miescher S, Whiteside TL, Carrel S, von Fliedner V. Functional properties of tumor-infiltrating and blood lymphocytes in patients with solid tumors: effects of tumor cells and their supernatants on proliferative responses of lymphocytes. J Immunol 1986;136:1899-907.
7. Miescher S, Stoeck M, Qiao L, Barras C, Barrelet L, von Fliedner V. Preferential clonogenic deficit of CD8-positive T-lymphocytes infiltrating human solid tumors. Can Res 1988;48:6992-8.
8. Vose BM, Moore M. Supressor cell activity of lymphocytes infiltrating human lung and breast tumours. Int J Cancer 1979;24:579-85.
9. Asher AL, Mulé JJ, Kasid A, et al. Murine tumor cells transduced with the gene for tumor necrosis factor-α: evidence for paracrine immune effects of tumor necrosis factor against tumors. J Immunol 1991;146:3227-34.
10. Gansbacher B, Bannerji R, Daniels B, Zier K, Cronin K, Gilboa E. Retroviral vector-mediated γ Interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity. Can Res 1990;50:7820-5.
11. Fearon ER, Pardoll DM, Itaya T, et al. Interleukin 2 production by tumor cells bypasses T helper function in the generation of an antitumor response. Cell 1990;60:397-403.
12. Dranoff G, Jaffel E, Lazenby A, et al. Vaccination with irradiated tumor cells engineered to secrete murine GM-CSF stimulates potent, specific, and long lasting anti-tumor immunity. Proc Natl Acad Sci USA 1993;90:3539-43.
13. Earth RJ, Mulé JJ, Spiess P, Rosenberg SA. Interferon γ and tumor necrosis factor have a role in tumor regressions mediated by murine tumor infiltrating lymphocytes. J Exp Med 1991;173:647-58.
14. Pisa P, Halapi E, Pisa EK, et al. Selective expression of interleukin 10, Interferon γ, and granulocyte-macrophage colony-stimulating factor in ovarian cancer biopsies. Proc Natl Acad Sci USA 1992;89:7708-12.
15. deWaal Malefyt R, Yssel H, deVries JE. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. J Immunol 1993;150:4754-65.
16. Wang P, Wu P, Siegel MI, Egan RW, Billah MM. IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells. J Immunol 1994;153:811-6.
17. Schlaak JF, Hermann E, Gallati H, Zum Buschenfelde KH, Fleischer B. Differential effects of IL-10 on proliferation and cytokine production of human γ/δ and α/β T cells. Scand J Immunol 1994;39:209-15.
18. deWaal Malefyt R, Abrams JS, Bennet BJ, Figdor CG, de Vries JE. IL-10 inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209-20.
19. Salgame P, Abrams JS, Clayberger C, et al. Differing lymphokine profile of functional subsets of human CD4 and CD8 T cell clones. Science 1991;254:279-82.
20. Martinez O, Gibbons R, Garavoy FJ, Aronson FR. IL-4 in-hibits IL-2 receptor expression and IL-2 dependent proliferation on human T cells. J Immunol 1990;144:2211-5.
21. Chen Y, Kuchroo V, Inobe J, Hafler D, Weiner H. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994;265:1237-40.
22. Kehrl JH, Wakefield LM, Roberts AB, et al. Production of transforming growth factor B by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med 1986;163:1037-50.
23. Elston CW, Gresham GA, Rao GS, et al. The cancer research campaign (King's/Cambridge) trial for early breast cancer: clinico-pathological aspects. Br J Cancer 1982;45: 655-69.
24. Dawson PJ, Karrsion T, Ferguson DJ. Histologic features associated with long term survival in breast cancer. Hum Pathol 1986;17:1015-21.
25. O) breast carcinoma. Ann Surg 1981;193:15-25.